Aptus Capital Advisors LLC Buys 114 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Aptus Capital Advisors LLC grew its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 36.5% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 426 shares of the financial services provider’s stock after buying an additional 114 shares during the quarter. Aptus Capital Advisors LLC’s holdings in iShares Biotechnology ETF were worth $62,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of IBB. Williams Financial LLC purchased a new stake in shares of iShares Biotechnology ETF in the second quarter valued at approximately $867,000. PVG Asset Management Corp purchased a new stake in shares of iShares Biotechnology ETF in the second quarter valued at approximately $415,000. Concourse Financial Group Securities Inc. boosted its holdings in shares of iShares Biotechnology ETF by 22.4% in the second quarter. Concourse Financial Group Securities Inc. now owns 656 shares of the financial services provider’s stock valued at $90,000 after purchasing an additional 120 shares during the period. Raymond James & Associates boosted its holdings in shares of iShares Biotechnology ETF by 4.4% in the second quarter. Raymond James & Associates now owns 189,766 shares of the financial services provider’s stock valued at $26,047,000 after purchasing an additional 7,931 shares during the period. Finally, First Financial Bank Trust Division purchased a new stake in shares of iShares Biotechnology ETF in the third quarter valued at approximately $204,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

iShares Biotechnology ETF stock opened at $133.38 on Monday. The business has a fifty day moving average of $144.49 and a two-hundred day moving average of $141.78. iShares Biotechnology ETF has a twelve month low of $116.70 and a twelve month high of $150.57.

iShares Biotechnology ETF Announces Dividend

The business also recently announced a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were issued a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.